Jeffrey M. Jonas, See Remarks at Sage Therapeutics, Inc. (SAGE), bought 6,000 shares at $18.00 ($108K) on 2014-07-23, disclosed to the SEC on 2014-07-23.
Open-market purchase of $108k SAGE by See Remarks. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Nothing distinguishes this filing.
| Filing → |
| KRTX | SELL | 2023-07-05 | $6.0M | — | Filing → |
| SAGE | SELL | 2023-02-10 | $1.0M | — | Filing → |
| SAGE | BUY | 2019-12-10 | $482K | — | Filing → |